Vipergen
PrivateCompany Overview
Vipergen is a biotechnology company that provides small molecule drug discovery services based on DNA-encoded library (DEL) technologies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
DNA-encoded libraryDEL technologysmall molecule discoverydrug discovery serviceslive-cell screeningcontract research organizationCROhit discoverydrug discovery CROintracellular screeningchemical library synthesisfee-for-servicefunded discovery partnershipsAI in drug discoverycrop protection
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vipergen Comparables
Compare Vipergen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| X-Chem | 87% | |
| NovAliX | 86% | |
| HitGen Inc. | 81% | |
Vipergen Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 16, 2025
Grew 25% QoQ from 12 to 15 employees.
Vipergen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vipergen's valuation, stock price, and market status.
Firmographic Details
HeadquartersCopenhagen
Employee Range14
Year Founded2005
Last Funding—
See something wrong or outdated?